IOP Pattern in Primary Angle Closure and Primary Angle Closure Glaucoma Patients, Before and After LPI

Sponsor
Sensimed AG (Industry)
Overall Status
Withdrawn
CT.gov ID
NCT01906151
Collaborator
(none)
0
1
1
1.9
0

Study Details

Study Description

Brief Summary

The purpose of the study is to determine the relationship of the intraocular pressure patterns recorded during 2 sessions using Triggerfish, before and after elective laser peripheral iridotomy in angle closure glaucoma patients

Condition or Disease Intervention/Treatment Phase
  • Device: SENSIMED Triggerfish®
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
A Prospective, Open Label Study Assessing the 24-hour Intraocular Pressure Pattern Monitored by SENSIMED Triggerfish® in Primary Angle Closure and Primary Angle Closure Glaucoma Patients, Before and After Laser Peripheral Iridotomy
Study Start Date :
Jan 1, 2014
Actual Primary Completion Date :
Mar 1, 2014
Actual Study Completion Date :
Mar 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Other: SENSIMED Triggerfish®

SENSIMED Triggerfish® (TF) is a CE-marked portable device that monitors the 24-hour intraocular pressure (IOP) pattern by a wireless contact lens sensor (CLS) placed on the eye that sends its signals wirelessly via a periorbital patched adhesive antenna to a recorder. Upon completion, the recording can be transmitted to a computer for read-out and visualization

Device: SENSIMED Triggerfish®
SENSIMED Triggerfish® (TF) is a CE-marked portable device that monitors the 24-hour intraocular pressure (IOP) pattern by a wireless contact lens sensor (CLS) placed on the eye that sends its signals wirelessly via a periorbital patched adhesive antenna to a recorder. Upon completion, the recording can be transmitted to a computer for read-out and visualization

Outcome Measures

Primary Outcome Measures

  1. To evaluate the differences between the nycthemeral intraocular pressure patterns recorded with Triggerfish during two 24-hour periods, in patients with Primary angle closure and Primary angle closure glaucoma, before and after laser peripheral iridotomy [24 hours]

Secondary Outcome Measures

  1. To assess the nycthemeral intraocular pressure patterns specific to primary angle closure and primary angle closure glaucoma [24 hours]

  2. To assess the effect of laser peripheral iridotomy on diurnal and nocturnal intraocular pressure pattern in primary angle closure and primary angle closure glaucoma [24 hours]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diagnosis of Primary Angle Closure (PAC) or Primary Angle Closure Glaucoma (PACG) with indication for Laser Peripheral Iridotomy (LPI). PAC is defined by the presence of a partial or complete iridotrabecular contact(ITC) in more than 2 quadrants with either raised intraocular pressure (IOP) (ie. more than 21 mmHg) and/or PAS; however, with normal optic disc and visual field. PACG is defined by the presence of ITC with either raised IOP and/or PAS, and evidence of glaucomatous optic disc and visual field

  • No IOP-lowering drug treatment or a 4-week wash-out period prior to Study Day 0

  • Aged ≥18 years, of either sex

  • Not more than 6 diopters spherical equivalent on the study eye

  • Have given written informed consent, prior to any investigational procedures

Exclusion Criteria:
  • History of acute angle closure glaucoma on the study eye

  • Secondary angle closure glaucoma on the study eye

  • History of ocular surgery within the last 3 months on the study eye

  • History of ocular laser treatment, including previous LPI on the study eye

  • Corneal or conjunctival abnormality precluding contact lens adaptation on the study eye

  • Severe dry eye syndrome on the study eye

  • Patients with allergy to corneal anesthetic

  • Patients with contraindications for silicone contact lens wear

  • Patients not able to understand the character and individual consequences of the investigation

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHNO des Quinze-Vingts, 28 rue Charenton Paris France 75571

Sponsors and Collaborators

  • Sensimed AG

Investigators

  • Principal Investigator: Christophe Baudouin, MD, CHNO des Quinze-Vingts, 28 rue Charenton, 75571 Paris Cedex 12, France

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sensimed AG
ClinicalTrials.gov Identifier:
NCT01906151
Other Study ID Numbers:
  • TF-1306
First Posted:
Jul 23, 2013
Last Update Posted:
May 13, 2014
Last Verified:
May 1, 2014
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 13, 2014